Home Tags FDA

FDA

CBD Oil Still Under Attack

Editor’s Note: This article is intended for information purposes only. Because state and municipal laws vary greatly, as do the circumstances of individual cases,...

Transparency Wins the Day

By Dagan Xavier, Co-Founder & Senior Vice President of Data at Label Insight On May 20, 2016, the FDA announced a new, improved Nutrition Facts...

FDA Officially Extends Nutrition Facts Label Compliance Date

Washington, D.C. - Food manufacturers have received an 18-month extension for meeting updated nutrition and serving size requirements on product labels. The U.S. Food and Drug...

FDA Panel Votes To Approve Epilepsy Medication Made with CBD Oil

Washington, D.C. - A Food and Drug Administration advisory panel yesterday unanimously recommended approval of an epilepsy medication made with CBD oil. If the agency...

Industry Applauds FDA’s Action Against Highly Concentrated Caffeine

Washington, D.C. - Industry leaders are reacting positively to the Food and Drug Administration’s (FDA) recently published guidance about the dangers of selling bulk...

FDA Study Reveals Presence of Pharmaceutical Drugs in Some Supplements

Washington, D.C. — A U.S. Food and Drug Administration (FDA) pilot study using portable screening devices has revealed the presence of pharmaceutical drugs in...

FDA Wants to Define What’s Natural and Healthy

Washington, DC — Food and Drug Administration Commissioner Scott Gottlieb says the agency is closer to issuing guidance on the the word "natural" and...

Now We Know Vitamin D Reduces Risk of Preterm Birth, What Next?

The Organic & Natural Health Association (@OrgNatHealth) is committed to research, especially when it’s designed to demonstrate how the supplements we take favorably impact...

New Analysis Supports Health Claims for Soy Protein and Heart Disease

Washington, D.C. - The Natural Products Association (NPA) this week provided the Food and Drug Administration (FDA) with details supporting health claims that soy protein...
FDA, FSMA, New Draft Guidance, Extends Deadline

Public Comment Period on FDA’s Homeopathy Ruling Extended for 60 Days

The Food and Drug Administration (FDA) has extended the public comment period for its Draft Guidance ruling on homeopathic drugs for 60 days, bringing...

BACK ISSUES

MULTIMEDIA